A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
Conditions: Vaccine-Preventable Diseases; Herpes Zoster Interventions: Biological: Recombinant Herpes Zoster Vaccine; Biological: Recombinant Herpes Zoster Vaccine Placebo Sponsors: Beijing Luzhu Biotechnology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Herpes | Research | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Varicella-Zoster Virus Vaccine